Short-term Clinical Effects of Intravitreal Aflibercept Injection 2.0mg as a Predictor of Long-term Results

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Valley Retina Institute
Information provided by (Responsible Party):
Rhonda Weeks, Retina Research Institute, LLC
ClinicalTrials.gov Identifier:
NCT01657669
First received: August 2, 2012
Last updated: December 11, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: January 2015
  Estimated Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)